BioNTech SE (NAS:BNTX)
$ 115.59 -1.61 (-1.37%) Market Cap: 27.71 Bil Enterprise Value: 9.82 Bil PE Ratio: 0 PB Ratio: 1.31 GF Score: 66/100

Q3 2019 BioNTech SE Earnings Call Transcript

Nov 14, 2019 / 01:00PM GMT
Release Date Price: $19 (+2.43%)
Operator

Thank you for joining us today for BioNTech's first quarterly conference call to provide a business update and discuss the financial results for the third quarter of 2019.

Before we start, we encourage you to view the slides for this webcast as well as the third quarter financial results press release issued this morning; both accessible on our website in the Investor Media section.

Also during the presentation, we will be making forward-looking statements regarding the development of BioNTech's platforms and technologies and the progress of its pipeline programs and our financial outlook.

Should actual results differ from the company's assumptions, ensuring actions may differ from those anticipated. You are, therefore, cautioned not to place undue reliance on any forward-looking statements, which speak only as of the date of this conference call and webcast. Speaking and available for questions today will be Ugur Sahin, CEO; Sean Marett, CBO and CCO; Sierk Pötting, CFO and COO; and Ãzlem Tureci, our Chief Medical Officer.

I now hand over to Ugur Sahin, BioNTech's

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot